MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock and...
$10,360K
Net cash provided by
financing activities
$8,797K
Canceled cashflow
$1,563K
Net increase
(decrease) in cash, cash...
$2,454K
Canceled cashflow
$6,343K
Principal payments on
venture debt
-$1,563K
Stock-based compensation
expense
$1,548K
Prepaid expenses and
other current assets
-$302K
Non-cashlease expense
$163K
Depreciation expense
$90K
Amortization of debt discount
and issuance costs
$33K
Net cash used in
operating activities
-$6,343K
Canceled cashflow
$2,136K
Net income (loss)
-$7,609K
Accrued expenses and
other current...
-$476K
Accounts payable
-$226K
Operating lease liability
-$168K
Back
Back
Cash Flow
Q32 Bio Inc. (QTTB)
Q32 Bio Inc. (QTTB)
source: myfinsight.com